Cannot redeclare control with same name "grid_2_qv_name_typography_text_decoration"
One practical consideration: higher-concentration solutions (2000mcg/mL or above) increase the risk of peptide aggregation during long-term storage, so unless your protocol specifically requires minimal injection volumes, a 1000mcg/mL concentration is the safer choice for multi-week studies
The FDA has placed MOTS-C in Category 2 of bulk drug substances for compounding, meaning there are noted safety risks that warrant restricted access
Understanding proper peptide reconstitution is essential before beginning any protocol, and our bacteriostatic water guide explains the preparation process in detail
We have also formulated it to have a tasty strawberry and vanilla taste, making daily supplementation more than enjoyable
However, even with precursors, the body still has to do the work of assembly